menu icon
Book your open day visit nowClick to book open day

Different course options

Full time | Charterhouse Square | 1 year | 18-SEP-23

Study mode

Full time

Duration

1 year

Start date

18-SEP-23

Key information
DATA SOURCE : IDP Connect

Qualification type

MSc - Master of Science

Subject areas

Medical Specialisations: P-Z Oncology

Course type

Taught

Course Summary

This programme gives you the foundation in molecular and cellular biology that is fundamental to cancer biology and research. You’ll study and contribute to the latest developments in curing cancer, such as novel drugs and gene therapy. You’ll also discover how new therapies are developed, evaluated and implemented; This MSc is also available for intercalating MBBS students.

  • Taught by the UK’s leading oncology experts – we’re ranked number one for cancer research (REF 2014)
  • Part-time and online programme options available, so you can fit your studies around your other commitments
  • Gives you a solid background in cancer therapy but then allows you to specialise
  • Comprehensive training in research methods and techniques
  • An ideal career boost: discover how to develop and implement new treatments

Facilities

  • State-of-the-art research facilities and dedicated teaching laboratory
  • Access to specialised scientists and clinicians
  • Full access to our library and online resources
  • Mentors for non-programme related support, including careers advice
  • A dedicated Teaching Centre for administrative support

Career paths

You’ll leave this programme with the clinical skills and experience necessary to pursue further academic research at PhD or MD level. This programme also provides a strong foundation if you want to work in biotech research, hospital settings or in industry.

Modules

On completion of this module you will have detailed knowledge on the principles and practice of drug development at all stages of the development process, including: Ethical and good practice issues; What a therapeutic target is; How novel therapeutic targets are identified; How therapeutic targets are validated; Early clinical trials methodology.

Tuition fees

UK fees
Course fees for UK students

For this course (per year)

£12,250

International fees
Course fees for EU and international students

For this course (per year)

£26,750

Entry requirements

2:1 or above at undergraduate level in a relevant subject such as Biology, Chemistry, Pharmacology, Medicine from a recognised academic institution; Applicants with a 2:2 degree will be considered on an individual basis. The programme is open to graduate scientists, clinicians and other medical professionals working in healthcare, the pharmaceutical industry or contract research organisations.

University information

Queen Mary University of London (QMUL) is an internationally regarded public research institution based in London. It has a long history, dating back over 230 years, and is a member of the prestigious Russell Group of universities. QMUL has five campuses in the city of London and an international network of satellite campuses in China, Malta and Paris. There is a population of around 16,000 students at the London campuses and more than 32,000...more